Works matching AU Lin, Hongxia


Results: 34
    1
    2
    3

    A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 1, p. 49, doi. 10.1007/s00280-021-04350-x
    By:
    • Tan, Antoinette R.;
    • Chan, Nancy;
    • Kiesel, Brian F.;
    • Stein, Mark N.;
    • Moss, Rebecca A.;
    • Malhotra, Jyoti;
    • Aisner, Joseph;
    • Shah, Mansi;
    • Gounder, Murugesan;
    • Lin, Hongxia;
    • Kane, Michael P.;
    • Lin, Yong;
    • Ji, Jiuping;
    • Chen, Alice;
    • Beumer, Jan H.;
    • Mehnert, Janice M.
    Publication type:
    Article
    4
    5

    Methane Oxidation over the Zeolites-Based Catalysts.

    Published in:
    Catalysts (2073-4344), 2023, v. 13, n. 3, p. 604, doi. 10.3390/catal13030604
    By:
    • Wu, Linke;
    • Fan, Wei;
    • Wang, Xun;
    • Lin, Hongxia;
    • Tao, Jinxiong;
    • Liu, Yuxi;
    • Deng, Jiguang;
    • Jing, Lin;
    • Dai, Hongxing
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    A second target of benzamide riboside.

    Published in:
    Cancer Biology & Therapy, 2012, v. 13, n. 13, p. 1290, doi. 10.4161/cbt.21786
    By:
    • Roussel, Breton;
    • Johnson-Farley, Nadine;
    • Kerrigan, John E.;
    • Scotto, Kathleen W.;
    • Banerjee, Debabrata;
    • Felczak, Krzysztof;
    • Pankiewicz, Krzysztof W.;
    • Gounder, Murugesan;
    • Lin, Hongxia;
    • Abali, Emine Ercikan;
    • Bertino, Joseph R.
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34